2. Krause PR, Gruber MF. 2020; Emergency use authorization of covid vaccines-safety and efficacy follow-up considerations. N Engl J Med. 383:e107. DOI:
10.1056/NEJMp2031373. PMID:
33064383.
3. Choi JK, Kim S, Kim SR, et al. 2021; Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in Korea. J Korean Med Sci. 36:e223. DOI:
10.3346/jkms.2021.36.e223. PMID:
34402235. PMCID:
PMC8352786.
Article
4. Weintraub K. 2021. Jan. 6. Death of Florida doctor after receiving COVID-19 vaccine under investigation. USA Today.
5. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. 2021; Thrombo-cytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 39:3329–32. DOI:
10.1016/j.vaccine.2021.04.054. PMID:
34006408. PMCID:
PMC8086806.
Article
6. Sangli S, Virani A, Cheronis N, et al. 2021; Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine. Ann Intern Med. 174:1480–2. DOI:
10.7326/L21-0244. PMID:
34181446. PMCID:
PMC8251935.
Article
7. Al-Maqbali JS, Al Rasbi S, Kashoub MS, et al. 2021; A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. Am J Case Rep. 22:e932946. DOI:
10.12659/AJCR.932946. PMID:
34117206. PMCID:
PMC8212841.
Article
10. Thiele T, Ulm L, Holtfreter S, et al. 2021; Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. Blood. 138:299–303. DOI:
10.1182/blood.2021012217. PMID:
33988688. PMCID:
PMC8129797.
Article